Woodcock defends FDA's response to Omicron before Senate health committee

In what may be Janet Woodcock’s final congressional hearing as the head of the FDA, she once again offered a candid description of the difficulties of battling the current Omicron outbreak.

Speaking through two masks alongside other CDC, NIH and HHS leaders, Woodcock compared the current pandemic to a natural disaster, adding, “I don’t think it will last a really long time.”